메뉴 건너뛰기




Volumn 16, Issue 5, 1988, Pages 297-303

High‐dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude total therapy study X

Author keywords

chemotherapy; complete remission; cranial irradiation; survival

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

EID: 0023697605     PISSN: 00981532     EISSN: 1096911X     Source Type: Journal    
DOI: 10.1002/mpo.2950160502     Document Type: Article
Times cited : (53)

References (35)
  • 8
    • 0017239475 scopus 로고
    • Factors that influence haematological remission duration in acute lymphocytic leukemia
    • (1976) Br J Haematol , vol.32 , pp. 465-472
    • Simone, JV1
  • 11
    • 0019839531 scopus 로고
    • Immunological definition of leukemia cell surface phenotypes
    • (1981) Cancer Res , vol.41 , pp. 4790-4793
    • Melvin, SL1
  • 17
    • 84989609522 scopus 로고    scopus 로고
    • Prospective study of central nervous system changes in children with acute lymphoblstic leukemia receiving two different methods of central nervous system prophylaxis. Neurotoxicology (in press).
    • Ochs, J1    Parvey, LS2    Mulhern, R3
  • 26
    • 0019790924 scopus 로고
    • Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Report on a national treatment program
    • (1981) Haematologia , vol.14 , pp. 257-263
    • Moe, PJ1    Seip, M2    Finne, PH3
  • 35
    • 0023249618 scopus 로고
    • Controversies in the management of childhood acute lymphoblastic leukemia: Treatment intensification, CNS leukemia and prognostic factors
    • (1987) Semin Hematol , vol.24 , pp. 12-26
    • Rivera, GK1    Mauer, AM2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.